US Patent 11608500 Gene-regulating compositions and methods for improved immunotherapy

Patent

US Patent 10166257 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10266850 Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

US Patent 10272113 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10286066 Artificial antigen presenting cells and uses thereof

US Patent 10363273 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10398734 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10420799 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10463697 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 11111493 Gene-regulating compositions and methods for improved immunotherapy

US Patent 10537595 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 11857574 Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence

United States Patent and Trademark Office

Arthur S Leonard